Edwards Lifesciences Corporation · NYSE:EW

Edwards Lifesciences — Shareholder Meeting (March 2023)

11 slides from Edwards Lifesciences's shareholder meeting presentation, Mar 28, 2023

  1. Slide 1: Edwards Lifesciences Spring 2023 Stockholder Engagement

    Edwards Lifesciences Spring 2023 Stockholder Engagement

  2. Slide 2: Cautionary Statement and Use of Non-GAAP Financial Measures

    Cautionary Statement and Use of Non-GAAP Financial Measures 2  This presentation may include forward-looking statements, including, but not limited to, financial forecasts, that involve risks and uncertainties that could cause actual results or experience to differ materially from historical result

  3. Slide 3: We Request Your Support at the 2023 Annual Meeting of Stockholders

    We Request Your Support at the 2023 Annual Meeting of Stockholders 3 Proposal 1. FOR Election of Nine Director Nominees Proposal 2. FOR Advisory Vote to Approve Named Executive Officer Compensation Proposal 3. ONE YEAR Advisory Vote to Approve Frequency of Future Advisory Votes on Named Executive Of

  4. Slide 4: Our Credo

    Our Credo We will celebrate our successes, thrive on discovery, and continually expand our boundaries. We will act boldly, decisively, and with determination on behalf of people fighting cardiovascular disease. At Edwards Lifesciences, we are dedicated to providing innovative solutions for people fi

  5. Slide 5: Edwards Lifesciences at a Glance

    Edwards Lifesciences at a Glance 5 COMPANY OVERVIEW 800K+ Patients Treated with Transcatheter Therapies 85%+ Charitable employee engagement ~95% Sales from Products with #1 Global Position PATIENT-FOCUSED INNOVATION STRATEGY Lead groundbreaking standards of care through trusted relationships Leaders

  6. Slide 6: Patient-Focused Innovation Strategy has Produced Sustained Sales Growth

    Edwards Lifesciences SPSIHE S&P 500 Edwards’ Patient-Focused Innovation Strategy has Produced Sustained Sales Growth 6 $1.9 $2.0 $2.3 $2.5 $3.0 $3.4 $3.7 $4.3 $4.4 $5.2 $5.4 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023E Edwards Sales ($ in billions) $5.6 - $6.0(1) Focused on opportuni

  7. Slide 7: CEO Pay Element Components and Performance Measures

    CEO Pay Element Components Corporate Performance Measures & Rationale Base Salary Cash  Attract and retain qualified executives Annual Cash Incentive(1) Corporate Financial Measurement  Based on underlying revenue growth, adjusted earnings per share, and adjusted free cash flow targets set at the

  8. Slide 8: Refreshed Board with a Thoughtful Leadership Structure

    33% 56% 11% Tenure 33.3% 66.7% Gender Men Women Refreshed Board with a Thoughtful Leadership Structure 8 Michael A. Mussallem(1) Joined in 2000 Non-executive Chairman, Edwards Lifesciences Bernard J. Zovighian(2) 2023 Nominee CEO, Edwards Lifesciences Medical Technology Industry Experience Internati

  9. Slide 9: Board Recommends Vote Against the Proposal Regarding Independent Board Chairman

    Board Recommends Vote Against the Proposal Regarding Independent Board Chairman 9 EFFECTIVE INDEPENDENT LEADERSHIP ROBUST LEAD INDEPENDENT DIRECTOR RESPONSIBILITIES  Reviews and approves Board meeting agendas, time allotments and information provided to directors  Serves as a liaison between the i

  10. Slide 10: Commitment to Stockholder Engagement and Responsiveness

    10 Commitment to Stockholder Engagement and Responsiveness We have consistently contacted stockholders holding >50% of outstanding stock each year since 2015 to discuss topics of interest with active participation from our Lead Independent Director 20 2 3 20 1 9 20 1 5 DISCUSSION TOPICS Governance f

  11. Slide 11: Slide 11

Edwards Lifesciences — Shareholder Meeting (March 2023) on 6ix